SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-023168
Filing Date
2024-02-29
Accepted
2024-02-29 16:34:26
Documents
1
Period of Report
2024-02-27

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6962
  Complete submission text file 0000950170-24-023168.txt   8436
Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O KYMERA THERAPEUTICS, INC. 200 ARSENAL YARDS, SUITE 230 WATERTOWN MA 02472
Business Address
Gollob Jared (Reporting) CIK: 0001821198 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 24704360